Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MiMedx Group, Inc.(MDXG) | 28,195,249 | 28,195,249 | 0 | $271.24M | $214.28M | 61.81% | -$56.95M |
| Bioventus Inc.CL A(BVS) | 13,021,324 | 13,021,324 | 0 | $136.72M | $119.15M | 34.37% | -$17.58M |
| EyePoint, Inc.(EYPT) | 1,169,857 | 1,169,857 | 0 | $8.72M | $6.34M | 1.83% | -$2.37M |
| TELA Bio, Inc.(TELA) | 4,110,709 | 4,110,709 | 0 | $12.41M | $5.02M | 1.45% | -$7.40M |
| MediciNova, Inc.(MNOV) | 1,105,941 | 1,105,941 | 0 | $2.32M | $1.61M | 0.47% | -$707.8K |
| Venus Concept Inc | 0 | 99,021 | +99,021 | $0 | $276.3K | 0.08% | +$276.3K |
| Revance Therapeutics Inc | 457,085 | 0 | -457,085 | $1.39M | $0 | — | -$1.39M |
| Venus Concept, Inc. | 1,089,190 | 0 | -1,089,190 | $413.9K | $0 | — | -$413.9K |